ENGINEERING

BRISBANE, CA -- X-MINE Inc today introduced X-Refiner(TM) 1.0, the company's leading informatics platform for genomic knowledge discovery. X-Refiner(TM) 1.0 constitutes an integrated and searchable catalog of millions of database entries containing reports, annotations, comments, HTML, XML, images, and links to external data sources, including protein and drug structures for streamlining the drug discovery process. "The most impressive functionality of X-Refiner is its algorithms for generating relationships," said Sandip Ray, President and CEO of X-MINE. "X-Refiner uses a visual interface to explore significant structural and functional relationships between drugs and proteins by uncovering associations between them found outside of normal data sources. We believe that with further development this will lead the way in making virtual drug screens a reality." X-Refiner(TM) provides a database cluster architecture to store and query multiple gene, nucleotide, drug, and protein databases. A reporting engine communicates with the database cluster and a dynamic annotation component to enhance prior knowledge about a gene, drug, or protein by gathering relevant data and commentary from the database cluster to produce both summarized and comprehensive reports. X-Refiner(TM) is further enabled by a natural intelligence engine for mining text, biological pathways, and mining tools to categorize, redistribute, and organize disparate data. Founded by leaders in the field of genomics from MIT/Whitehead Institute and Stanford University, X-MINE is a genomic knowledge discovery company. X-MINE offers partnerships in molecular pattern recognition, bioinformatics, and unrivaled knowledge expertise for predictive medicine and diagnostics. X-MINE products and partnerships address the single largest cost issue in drug discovery and development, namely, validation of product candidates early in the development process, enabling researchers to devote valuable time and resources for development of products most likely to impart real benefit for disease, in a reduced timeframe. For more information visit www.x-mine.com